Tranzactioneaza Cue Biopharma (US.CUE) - 30.93 USD (%) Tranzactioneaza
1D
1W
1M
3M
6M
1Y
5Y
Max
Indici
Descriere companie
Cue Biopharma Inc (www.cuebiopharma.com) is a development-stage immunotherapy company. The Company is focused at developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease. Its Immuno-Oncology pipeline includes CUE-100 Framework, and CUE-200 Framework; and autoimmune pipeline includes MHC Class I Program, and MHC Class II Program. The CUE-100 Framework restricts the activity of T cell populations. The CUE-200 Framework enables potent, long-lived anti-tumor T cell responses. The Autoimmune disease therapy protects the healthy cells from immune attack.